Module 1 Objectives Regenerative Cell Therapy. Module 1. Why Use Regenerative Cell Therapy? What is Regenerative Medicine? Regenerative Therapy Goals

Similar documents
Regenerative Medicine for Joint Disease. Regenerative Medicine for Joint Disease. Regenerative Medicine for Joint Disease

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018

At the conclusion of this lesson you should be able to:

YOUR OWN LIFE

Stem cells and tissue engineering

Regenerative Medicine and Stem Cell Therapies

THE THERAPEUTIC REALITIES OF STEM CELLS

Regenerative Medicine. Speaker Disclosures. What is regenerative medicine? 6/22/2016

How You Can Use Stem Cells

What Are Stem Cells? Where Are These Stem Cells?

Discover TruPRP. PRP the way you want it.

BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.

Cell-based therapies in tissue engineering and regenerative medicine (TE/RM)

NPTEL Biotechnology Tissue Engineering. Stem cells

Stem Cell Research From Bench to Bedside

T H E R A P Y REGENERATIVE MEDICINE NATURAL EFFECTIVE LIFE-CHANGING

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

Mesenchymal Stem Cell Characterization. Peiman Hematti, M.D. Department of Medicine

FDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps

Mesenchymal Stromal/Stem Cells

Stem Cells, Regenerative Medicine and cgmp (GTP)

The Role of Adult Stem Cells in Personalized and Regenerative Medicine

Mesenchymal Stromal Cells Large-scale Culture

INTRODUCTION OF BIOCELLULAR REGENERATIVE MEDICINE

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL

Des cellules-souches dans le poumon : pourquoi faire?

Leading the world in novel adult stem cell therapies Half-Year Financial Results

Available through Online

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE

Stem cell: a cell capable of 1) tissue plasticity - make different cell types 2) infinite self renewal through asymmetric division

Double Syringe System Autologous Conditioned Plasma

Assuring Multipotency of human Mesenchymal Stem Cells (hmsc)

Introduction to Cell/ Biomaterial Engineering

Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords

Erectile and voiding dysfunction: will stem cells solve it all?

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development

Lyset BOOST YOUR CELL CULTURE TODAY FOR THE EXPERIMENTS OF TOMORROW

3/20/2017. R 3 Repair Paradigm REGENERATIVE MEDICINE GLOSSARY OF STEM CELL PLATFORMS. Limitations of Embryonic Stem Cells

THE SCIENCE OF PLATELET RICH PLASMA

ANAT 2341 Embryology Lecture 18 Stem Cells

About ATCC. Established partner to global researchers and scientists

Growth factor delivery

PRP Preparation. Simplicity for Success

Discover TruPRP. PRP the way you want it.

Andrew Finnerty General Manager - CCMI

CELL THERAPY FOR THE TREATMENT OF DAMAGED MYOCARDIUM

Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis

Introduction to Cell- Biomaterial Engineering!

STEM CELLS BONE FRACTURE

PRODUCT REPORT. Premiere Regenerative Medicine.

Stem Cells & Neurological Disorders. Said Ismail Faculty of Medicine University of Jordan

All contents herein are the sole property of MEDIPOST Co., Ltd. Any reproduction or distribution of this document without the written consent of

ARTHREX ACP. Features and Benefits: Introduction

Introduction to Cell and Biomaterial Engineering! Module 3, Lecture 1!! Spring 2014!

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)

Special Issue. Mesoblast Limited

Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation

TISSUE ENGINEERING AND REGENERATION: TECHNOLOGIES AND GLOBAL MARKETS

Promises and Challenges

Background. Background. Background. Background. Background 3/4/2013

Genetics Lecture 19 Stem Cells. Stem Cells 4/10/2012

Stem Cell Research 101

SmartPReP 2: The Gold Standard

Leading the world in the development of adult stem cell therapies. June 2014

EMA s role & responsibility for the development of modern/advanced therapies

Cell membrane repair in acute lung injury: from bench to bedside. Disclosure. Cell membrane repair is an elemental physiological process

Presenter: Teresa Holm

Nanosystems in regenerative medicine. Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden

STEM CELL RESEARCH PRIMER

Future of Stem Cell Engineering. Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST

ASX Spotlight Conference

ASX Spotlight Conference

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

Stem cells in Development

ANAT 3231 Cell Biology Lecture 21 Stem Cells

hpsc Growth Medium DXF Dr. Lorna Whyte

What are the origins of medical practice? Humans have been involved with medical biotechnology

Stem cells in Development

SNC2D BIOLOGY 3/31/2013. TISSUES, ORGANS & SYSTEMS OF L Stem Cells & Meristematic Cells (P.40-41) Specialized Cells. Stem Cells

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics

WHAT IS EMBRYONIC STEM CELLS

Stem cells and motor neurone disease

BME 177. Engineering stem cells. Gayatri Pal Lecturer Biomolecular Engineering

INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE

The Ultimate Guide To STEM CELL THERAPY. for Joint Disorders

ANNOUNCEMENTS. HW2 is due Thursday 2/4 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134)

Tissue Engineering and Regenerative Medicine

Science Dialogue. By: Dr. Ahmed Hegab, PhD Dr. Hiroshi Kubo, MD, PhD. Hachinohe-Kita High School

TROPOCELLS TM PLUS. PRP Preparation Simplicity for Success

Production and commercialisation of vascularized and customized bone Clinical trials, market authorisation Pre-clinical trials

PTH Effects Bone Healing and Vasculogenesis in Calvaria Bone Allograft Model

The Power in You. TM

Stem Cel s Key Words:

The Science of Stem Cell Therapy

Clip 1: Hip dysplasia Clip 2: Vet-Stem s Dr. Harman

for SCI: Challenges for Entry and Execution of Phase 1 Clinical Trials Challenges and Opportunities of Cellular Therapeutic Development

RegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength.

Stem Cell. Running head: STEM CELL RESEARCH. Stem Cell Research. Student s Name. University Affiliation

Michael N. Brown, MD, DC

Transcription:

Module 1 Principles of Regenerative Medicine Module 1 Objectives Regenerative Cell Therapy Learn why to use regenerative cells Learn what they are Learn the relevant mechanisms of action Learn why adipose is a rich source Learn the basics of collection and use 1 2 What is Regenerative Medicine? You are ALIVE because you continuously renew (rejuvenate) various tissues/organs. In every tissue in which this rejuvenation process occurs, a source exists which gives rise to these differentiated cells. The source is called a STEM CELL. - Arnold Caplan, PhD Lack of satisfactory therapy for degenerative disease Osteoarthritis Autoimmune diseases Poor healing Why Use Regenerative Cell Therapy? Non-union fractures Tendon/ligament injuries Wounds Case Western Reserve University Father of the Mesenchymal Stem Cell 3 4 Regenerative Therapy Goals Maximize Strength Range of Motion Performance Reduce Doesn t Matter Your Job Title! Scars Pain Future Disease 5 6

7 8 What are Stem Cells? Stem Cells are Primitive cells present in almost every tissue Able to become different types of tissue: Tendon Bone Ligament Self-renewing Trophic Factories Courtesy, NIH Stem Cell website Embryonic vs Adult Stem Cells Embryonic Stem Cells Source: inner cell mass of embryo Intended to form a whole animal - not for repair Gruen L and Grabel L, Concise Review: Scientific and Ethical Roadblocks to Human Embryonic Stem Cell Therapy. Stem Cell 2006;24;2162-2169. 9 10 Embryonic vs Adult Stem Cells Embryonic Stem Cells Source: inner cell mass of embryo Intended to form a whole animal - not for repair Form Teratomas in-vivo UNPREDICTABLE Rejected due to foreign genotype Embryonic vs Adult Stem Cells Adult Stem Cells Source: most adult tissues contain them Ability to differentiate into many tissues (multi-potent) Do not form teratomas except in extreme in-vitro If autologous, no chance for rejection Gruen L and Grabel L, Concise Review: Scientific and Ethical Roadblocks to Human Embryonic Stem Cell Therapy. Stem Cell 2006;24;2162-2169. 11 12

DR. HELEN BLAU, Stanford University School of Medicine: Adult stem cells, until recently, were thought to be tissue-specific. That is the skin had its own stem cells, and the liver had its own stem cells, and muscle. And now stem cells have been considered something broader in the adult, and this was quite unexpected. July 14, 2004. Xenogeneic Donor Cell Sources Definition: Tissues from a different species Example: Pig heart valves, porcine hepatocytes Allogeneic Definition: Tissues from same species different individual Example: Bone marrow transplant, heart transplant Autologous Definition: Recipient supplies tissue for own transplant Example: Blood bank before surgery, skin transplant, tendon relocation 13 14 Adult Stem Cell Sources Bone Marrow Adipose Muscle Skin Brain Nasal Nerve Many others 15 16 1. Trophic support - growth factors and cytokines 2. Anti-inflammatory 3. Differentiation into tissue 4. Homing to injury site 5. Immune System Modulation 1. Trophic support growth factors and cytokines a. Anti-scarring b. Angiogenic (VEGF) c. Anti-apototic (block cell death after injury) d. Stimulation of resident tissue stem cells Caplan and Dennis, J Cell Biochem, 2006 17 18

Ischemia Model Adipose Cell Therapy 7 Days post ischemia Saline Control DR. JAMES WILLERSON, University of Texas Health Science Center: The patients that were treated had better blood flow to their hearts and better local function of their heart where we'd injected the cells and better overall function of their heart. And they'd also improved symptomatically, so much so that at least two or three of the original 14 not only could do more, but they were now jogging on the beach. Adipose Stem Cell Treated Laser Doppler Blood Flow Miranville, Circulation, 2004 19 20 Factors Secreted by Mesenchymal Stem Cells* Interleukins IL-3, IL-6, IL-7, IL-8,IL-11, IL-12, IL-14, IL-15 Neurotrophic Factors NGF, BDNF, GDNF 2. Anti-inflammatory Decrease pro-inflammatory mediators Increase anti-inflammatory mediators Growth Factors and Cytokines LIF, VEGF, HGF, SDF, SCF, M-CSF, bfgf, IGFBP, Oncostatin M, MIP1-, TIMP-1, TIMP-2, TGF-1, TGF-2, PDGF, EGF, KGF * Rehman et al, Circulation 2004, 109:1292-98 Nakagami et al, J Atheroscler Thromb 2006, Apr 13(2): 77-81 Tholpady et al, Clin Plastic Surg, 2006 21 22 3. Differentiation into tissue Osteogenic Assay: Alkaline Phosphatase and Von Kossa Staining of Differentiated ASCs Cardiac Muscle Liver Control Wells Nerve Fat-derived Stem Cells Angiogensis/ Anti-apoptosis No bone formation Bone Cartilage Gene Therapy Fat Tholpady et al, Clin Plastic Surg, 2006 (Photo courtesy Cytori Therapeutics) 23 Test Wells Equine ADAS cells Vet-Stem data 24 Bone formation

Human Therapy 4. Homing to injury site Journal of Cranio-Maxillofacial Surgery (2004) 32, 370 373 European Association for Cranio-Maxillofacial Surgery Damaged cartilage Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report MSCs Photo Courtesy Cognate Therapeutics 25 25 26 Human Therapy Osiris Therapeutics Announces Positive Results in Groundbreaking Stem Cell Trial to Treat Heart Disease-Intravenous Therapy Resulted in Statistically Significant Improvement Over Placebo in Multiple Safety and Efficacy Endpoints Baltimore, Mar 25, 2007 5. Immune System Modulation Texas Heart Institute at St. Luke s Episcopal Hospital Leads World s First Adult Stem Cell Study Using Patient s Own Fat Tissue Groh et al, Expt Hemat, 2005 27 27 28 Human Therapy Osiris Therapeutics Reports Positive Phase II Results Using PROCHYMAL(TM) for the Treatment of Acute Graft vs. Host Disease-Stem Cell Therapy Resulted in a 74% Complete Response Rate in a Life Threatening Disease That Currently Has No Approved Treatment BALTIMORE, Nov 09, 2006 29 29 30 30

The Injury Response Cascade Stem Cells in Injury Response Inflammation Magnitude Regeneration Fibrosis Magnitude Inflammation Regeneration Acute Injury QUICK FIX Time Scar Complete Acute Injury Time Fibrosis Scar Absent 31 Courtesy, Arnold Caplan, Case Western Reserve 32 Courtesy, Arnold Caplan, Case Western Reserve REGENERATIVE MEDICINE REGENERATE TISSUES TROPHIC BIOACTIVE FACTORS TURNOVER/ IMMUNO- MAINTAINANCE SUPRESSIVE MICROENVIRONMENT/ Courtesy, Arnold Caplan, MILEAU 33 Case Western Reserve Roles / Functions Stem cells are injury-specific, perfectly choreographed pharmaceutical factories Dr. Arnold Caplan Case Western Reserve Influence by injury micro-environment 34 PubMed Literature Search Last year 219 Last 5 years 600 Total Hits 1,074 35 36

Why Adipose? Why Adipose? High healing cell count No culturing required Family of healing cells Easy to access Renewable resource Rapid autologous source Autologous Adipose Characteristics FDA no regulation of autologous cells if minimally manipulated Safety low rejection risk Disease transmission very low Rapid Turnaround no wait for culturing 37 38 What Cells Do We Use?* How do we characterize? Regenerative (progenitor-type) Cells 63.3% Adipose-derived Stem Cell Types 34.6% Endothelial Types (vascular progenitor) 12.2% Vascular Smooth Muscle + Pericyte 10.3% Hematopoetic Stem Cell Type 6.2% Other Tissue Cells 22.5% Leukocytes 14.2% TOTAL 100.0% RESEARCH Visual (cytospin, morphology) Flow Cytometry CD Markers Growth rate, morphology CFU-F Assays (adherence) Differentiation Assays Osteo, Chondro *Varma et al, Stem Cells and Development 2007:91-104 (freshly isolated human adipose) 39 40 How do we characterize? COMMERCIAL RELEASE Cell counts (yield) Visual quality assessment Viability (trypan blue exclusion) Sample weight Sample temperature 41 42

Service Overview Adipose Tissue Harvest Inguinal Approach 43 Alternate Sites: Thoracic Approach, Falciform fat, or any other subcutaneous fat location 44 Adipose Tissue Harvest Thoracic Approach Vet-Stem Adipose Collection Kit Alternate Site: Falciform fat 1. Sterile Collection tubes 2. Cryo-block 3. Submission form 4. Owner Consent form 45 46 Vet-Stem Laboratory San Diego Vet-Stem Adipose Processing Lab 47 48

Cell Count and Viability Assessment Complete Injections while holding needle in place. 49 50 Stem Cell Banking Excess cells can be banked Storage is in liquid nitrogen Cell viability +14 years* * Spurr et al, Cryobiology, 2002 (human stem cells) Summary of Principles of Regenerative Medicine Adipose derived cells are a mix of stem and multipotent progenitors Adult sources avoid many pitfalls of embryonic Adipose is a rich source of stem and regenerative cells that can be easily collected, concentrated and utilized 51 52 Summary of Principles of Regenerative Medicine Regenerative cells function by Trophic actions Anti-inflammatory regulation Differentiation into needed tissues Homing to injury Immune modulation 53